Literature DB >> 3486220

Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor.

D Y Mochizuki, J R Eisenman, P J Conlon, L S Park, D L Urdal.   

Abstract

The expression in yeast of a cDNA clone encoding murine granulocyte-macrophage colony-stimulating factor (GM-CSF) has made possible the purification of large quantities of this recombinant protein. Rabbits immunized with pure recombinant GM-CSF generated antibodies that were shown to be specific for both recombinant GM-CSF and GM-CSF isolated from natural sources. Other lymphokines, including IL 1 beta, IL 2, IL 3, and recombinant human GM-CSF did not react with the antiserum. The antiserum, together with recombinant GM-CSF that had been radiolabeled with 125I to high specific activity, formed the foundation for a rapid, sensitive, and quantitative radioimmunoassay specific for murine GM-CSF. Furthermore, the antiserum was found to inhibit the biologic activities of GM-CSF as measured in both a bone marrow proliferation assay and a colony assay, and thus should prove to be a useful reagent for dissecting the complex growth factor activities involved in murine hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486220

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  D E Williams; D C Bicknell; L S Park; J E Straneva; S Cooper; H E Broxmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Isolation of a murine osteoclast colony-stimulating factor.

Authors:  M Y Lee; D R Eyre; W R Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.

Authors:  B M Curtis; B Gallis; R W Overell; C J McMahan; P DeRoos; R Ireland; J Eisenman; S K Dower; J E Sims
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Differential induction of bone marrow macrophage proliferation by mycoplasmas involves granulocyte-macrophage colony-stimulating factor.

Authors:  P M Stuart; G H Cassell; J G Woodward
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

Authors:  D Y Mochizuki; J R Eisenman; P J Conlon; A D Larsen; R J Tushinski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A.

Authors:  M Bickel; H Tsuda; P Amstad; V Evequoz; S E Mergenhagen; S M Wahl; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Properties of lymph-borne (veiled) dendritic cells in culture. I. Modulation of phenotype, survival and function: partial dependence on GM-CSF.

Authors:  G G MacPherson
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

8.  Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.

Authors:  H W Murray; J S Cervia; J Hariprashad; A P Taylor; M Y Stoeckle; H Hockman
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.

Authors:  M D Witmer-Pack; W Olivier; J Valinsky; G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.

Authors:  F Koch; C Heufler; E Kämpgen; D Schneeweiss; G Böck; G Schuler
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.